Ex-AveX­is crew trims staff at Chica­go-area Jaguar Gene Ther­a­py

Af­ter No­var­tis ac­quired AveX­is, ex­ec­u­tives from the lead­ing gene ther­a­py biotech shuf­fled off to form new star­tups look­ing to re­peat their Zol­gens­ma sto­ry for oth­er …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER